Literature DB >> 33912902

Changes in Seasonal Respiratory Illnesses in the United States During the COVID-19 Pandemic.

Loren Rodgers1,2, Michael Sheppard1, Amanda Smith1,3, Stephanie Dietz1, Praveena Jayanthi1,4, Yan Yuan1, Lara Bull1, Samantha Wotiz1,5, Tessa Schwarze6,7, Roseric Azondekon1, Kathleen Hartnett1,2, Jennifer Adjemian1,2, Hannah L Kirking2,8, Aaron Kite Powell1.   

Abstract

BACKGROUND: Respiratory tract infections are common, often seasonal, and caused by multiple pathogens. We assessed whether seasonal respiratory illness patterns changed during the COVID-19 pandemic.
METHODS: We categorized emergency department (ED) visits reported to the National Syndromic Surveillance Program according to chief complaints and diagnosis codes, excluding visits with diagnosed SARS-CoV-2 infections. For each week during March 1, 2020 through December 26, 2020 ("pandemic period"), we compared the proportion of ED visits in each respiratory category with the proportion of visits in that category during the corresponding weeks of 2017-2019 ("pre-pandemic period"). We analyzed positivity of respiratory viral tests from two independent clinical laboratories.
RESULTS: During March 2020, cough, shortness of breath, and influenza-like illness accounted for twice as many ED visits compared with the pre-pandemic period. During the last four months of 2020, all respiratory conditions, except shortness of breath, accounted for a smaller proportion of ED visits than during the pre-pandemic period. Percent positivity for influenza virus, respiratory syncytial virus, human parainfluenza virus, adenoviruses, and human metapneumovirus were lower in 2020 than 2019. Although test volume decreased, percent positivity was higher for rhinovirus/enterovirus during the final weeks of 2020 compared with 2019; with ED visits similar to the pre-pandemic period. DISCUSSION: Broad reductions in respiratory test positivity and respiratory emergency department visits (excluding COVID-19) occurred during 2020. Interventions for mitigating spread of SARS-CoV-2 likely also reduced transmission of other pathogens. Timely surveillance is needed to understand community health threats, particularly when current trends deviate from seasonal norms. Published by Oxford University Press for the Infectious Diseases Society of America 2021. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  COVID-19; Emergency Department Visits; Laboratory; Respiratory; Syndromic

Year:  2021        PMID: 33912902      PMCID: PMC8135472          DOI: 10.1093/cid/ciab311

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

1.  Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020.

Authors:  Natalie L Cobb; Sigrid Collier; Engi F Attia; Orvalho Augusto; T Eoin West; Bradley H Wagenaar
Journal:  PLoS Med       Date:  2022-07-19       Impact factor: 11.613

2.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

3.  Investigating the human rhinovirus co-infection in patients with asthma exacerbations and COVID-19.

Authors:  Abdullah Al-Dulaimi; Ahmad R Alsayed; Mohammed Al Maqbali; Malek Zihlif
Journal:  Pharm Pract (Granada)       Date:  2022-05-02

4.  Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.

Authors:  Kevin Messacar; Rachel E Baker; Sang Woo Park; Hai Nguyen-Tran; Jessica R Cataldi; Bryan Grenfell
Journal:  Lancet       Date:  2022-07-14       Impact factor: 202.731

5. 

Authors:  Pascal M Lavoie; Frederic Reicherz; Alfonso Solimano; Joanne M Langley
Journal:  CMAJ       Date:  2021-08-16       Impact factor: 8.262

6.  Rhinovirus Incidence Rates Indicate We Are Tired of Non-pharmacological Interventions Against Coronavirus Disease 2019.

Authors:  Min-Chul Kim; Joung Ha Park; Seong-Ho Choi; Jin-Won Chung
Journal:  J Korean Med Sci       Date:  2022-01-10       Impact factor: 2.153

7.  Respiratory Viral Infections in Athletes: Many Unanswered Questions.

Authors:  Olli Ruuskanen; Raakel Luoto; Maarit Valtonen; Olli J Heinonen; Matti Waris
Journal:  Sports Med       Date:  2022-03-30       Impact factor: 11.928

8.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infection during SARS-CoV-2 Infection.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  bioRxiv       Date:  2022-03-01

9.  Potential resurgence of respiratory syncytial virus in Canada.

Authors:  Pascal M Lavoie; Frederic Reicherz; Alfonso Solimano; Joanne M Langley
Journal:  CMAJ       Date:  2021-07-26       Impact factor: 8.262

10.  Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France.

Authors:  Jacques Fourgeaud; Julie Toubiana; Hélène Chappuy; Christophe Delacourt; Florence Moulin; Perrine Parize; Anne Scemla; Hanene Abid; Marianne Leruez-Ville; Pierre Frange
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.